{"log_id": 5022428938176346488, "direction": 0, "words_result_num": 36, "words_result": [{"probability": {"variance": 0.007317, "average": 0.970366, "min": 0.450595}, "location": {"width": 823, "top": 222, "height": 55, "left": 221}, "words": "随访2.7年,即总共随访6.8年。在HERS,HERSⅡ中,倍美安组和安慰剂组CHD事件的"}, {"probability": {"variance": 2e-06, "average": 0.998461, "min": 0.99517}, "location": {"width": 179, "top": 273, "height": 34, "left": 221}, "words": "发生率总体上相当"}, {"probability": {"variance": 1.4e-05, "average": 0.998131, "min": 0.980268}, "location": {"width": 809, "top": 307, "height": 57, "left": 222}, "words": "在一项针对男性的大规模前瞻性的临床试验中发现,大剂量雌激素(每天5mg结合雌"}, {"probability": {"variance": 0.000212, "average": 0.994122, "min": 0.924672}, "location": {"width": 813, "top": 338, "height": 55, "left": 222}, "words": "激素)、相当于治疗前列腺癌和乳腺癌的剂量,增加非致死性心肌梗塞,肺栓塞和血"}, {"probability": {"variance": 2e-05, "average": 0.996106, "min": 0.987435}, "location": {"width": 223, "top": 387, "height": 36, "left": 223}, "words": "栓性静脉炎的发生风险"}, {"probability": {"variance": 0.002506, "average": 0.952733, "min": 0.86992}, "location": {"width": 188, "top": 443, "height": 33, "left": 260}, "words": "静脉血栓栓塞(VTE"}, {"probability": {"variance": 0.002512, "average": 0.978432, "min": 0.786532}, "location": {"width": 820, "top": 452, "height": 54, "left": 224}, "words": "WH单用雌激素亚组研究报告服用倍美力的妇女静脉血栓栓塞(深静脉血栓[DVT]和"}, {"probability": {"variance": 0.002739, "average": 0.983279, "min": 0.689407}, "location": {"width": 814, "top": 481, "height": 55, "left": 223}, "words": "肺栓塞)风险增加(30例对22例每1000人年)。但只有深静脉血栓发生率的增加具"}, {"probability": {"variance": 0.00834, "average": 0.969875, "min": 0.447002}, "location": {"width": 762, "top": 513, "height": 51, "left": 226}, "words": "有统计学显著性(23例对15例每10000人一年)。在前两年观察到VTE风险的增加"}, {"probability": {"variance": 0.008559, "average": 0.938972, "min": 0.687318}, "location": {"width": 160, "top": 563, "height": 27, "left": 234}, "words": "(见[临床试验])"}, {"probability": {"variance": 0.006096, "average": 0.97012, "min": 0.587317}, "location": {"width": 819, "top": 592, "height": 56, "left": 226}, "words": "在WHI合用雌孕激素的亚组研究中,报告服用雌激素/孕激素妇女中,静脉血栓栓塞的"}, {"probability": {"variance": 0.010001, "average": 0.945635, "min": 0.634539}, "location": {"width": 851, "top": 617, "height": 63, "left": 225}, "words": "发生率为安慰剂组妇女VTE的2倍以上(35例对17例每1000年)差别有统计学显"}, {"probability": {"variance": 0.019338, "average": 0.944502, "min": 0.423103}, "location": {"width": 873, "top": 640, "height": 67, "left": 227}, "words": "著性。深静脉血栓(26例对13例每10000人年)和肺栓塞(18例对8例每1000年)"}, {"probability": {"variance": 0.000361, "average": 0.99227, "min": 0.905912}, "location": {"width": 805, "top": 680, "height": 56, "left": 227}, "words": "的风险也显示增加,并有统计学显著性。在第一年就观察到VTE风险的增加并且持续"}, {"probability": {"variance": 0.004598, "average": 0.937348, "min": 0.828237}, "location": {"width": 127, "top": 699, "height": 36, "left": 943}, "words": "药商务部"}, {"probability": {"variance": 0, "average": 0.998153, "min": 0.998043}, "location": {"width": 42, "top": 737, "height": 25, "left": 231}, "words": "下去"}, {"probability": {"variance": 0.000663, "average": 0.99472, "min": 0.83865}, "location": {"width": 814, "top": 765, "height": 54, "left": 229}, "words": "可能的话,在接受可能会导致血栓栓塞风险增高的手术前至少4-6周或者长期卧床期"}, {"probability": {"variance": 0, "average": 0.999616, "min": 0.998794}, "location": {"width": 175, "top": 817, "height": 27, "left": 232}, "words": "间,应停用雌激素"}, {"probability": {"variance": 0.001285, "average": 0.981793, "min": 0.901695}, "location": {"width": 126, "top": 873, "height": 28, "left": 194}, "words": "3.恶性肿瘤"}, {"probability": {"variance": 2.5e-05, "average": 0.992679, "min": 0.987732}, "location": {"width": 113, "top": 900, "height": 28, "left": 269}, "words": "子宫内膜癌"}, {"probability": {"variance": 1.7e-05, "average": 0.998143, "min": 0.978492}, "location": {"width": 812, "top": 904, "height": 57, "left": 231}, "words": "有完整子宫的妇女单独使用雌激素与子宫内膜癌风险的增加有关。据报道有完整子宫"}, {"probability": {"variance": 0.002515, "average": 0.988465, "min": 0.682169}, "location": {"width": 819, "top": 934, "height": 56, "left": 235}, "words": "的妇女单独使用雌激素发生子宫内膜癌的风险是不使用雌激素者的2一12倍,并且似乎"}, {"probability": {"variance": 8e-06, "average": 0.998102, "min": 0.983798}, "location": {"width": 812, "top": 964, "height": 54, "left": 232}, "words": "与使用雌激素的剂量和时间有关。大多数研究表明使用雌激素不足一年时,与使用雌"}, {"probability": {"variance": 1e-05, "average": 0.997953, "min": 0.986065}, "location": {"width": 803, "top": 993, "height": 55, "left": 231}, "words": "激素相关的子宫内膜癌的风险没有明显增加。最大的风险似乎和长期使用有关,用5"}, {"probability": {"variance": 0.007155, "average": 0.97505, "min": 0.492977}, "location": {"width": 800, "top": 1023, "height": 53, "left": 235}, "words": "10年或者更长者风险增加15-24倍:并且这种风险在停用雌激素后还至少维持8-15"}, {"probability": {"variance": 0, "average": 0.999772, "min": 0.999772}, "location": {"width": 24, "top": 1079, "height": 24, "left": 234}, "words": "年"}, {"probability": {"variance": 0.00018, "average": 0.992453, "min": 0.94355}, "location": {"width": 814, "top": 1103, "height": 57, "left": 233}, "words": "尚未证明在子宫内膜癌风险方面,等价剂量的天然雌激素和合成雌激素的差异。已表"}, {"probability": {"variance": 1.1e-05, "average": 0.998526, "min": 0.984494}, "location": {"width": 814, "top": 1134, "height": 54, "left": 234}, "words": "明在雌激素替代治疗中增加孕酮可以降低子宫内膜增生的风险。子宫内膜增生可能是"}, {"probability": {"variance": 4.3e-05, "average": 0.995172, "min": 0.976662}, "location": {"width": 507, "top": 1171, "height": 47, "left": 234}, "words": "子宫内膜癌的先兆病变(见有子宫的妇女应加用孕酮"}, {"probability": {"variance": 0.017212, "average": 0.945036, "min": 0.36058}, "location": {"width": 803, "top": 1218, "height": 54, "left": 256}, "words": "组WH研究(见[临床试验])表明,平均用药5.6年后,激素/孕酮联合组子宫内膜"}, {"probability": {"variance": 0.005051, "average": 0.981303, "min": 0.697058}, "location": {"width": 379, "top": 1260, "height": 40, "left": 236}, "words": "癌的风险程度与安慰剂组相比未见增加"}, {"probability": {"variance": 0.007967, "average": 0.974274, "min": 0.583315}, "location": {"width": 817, "top": 1299, "height": 56, "left": 238}, "words": "对所有联合服用雌/孕激素的妇女进行临床监测是重要的。对所有诊断不明的持续或反"}, {"probability": {"variance": 6.5e-05, "average": 0.995946, "min": 0.961973}, "location": {"width": 790, "top": 1330, "height": 53, "left": 239}, "words": "复的阴道异常出血的患者要采取恰当的诊断措施,包括有指征时进行子宫内膜活检"}, {"probability": {"variance": 4e-06, "average": 0.998772, "min": 0.994014}, "location": {"width": 155, "top": 1383, "height": 26, "left": 238}, "words": "以除外恶性疾病"}, {"probability": {"variance": 1e-06, "average": 0.98919, "min": 0.988079}, "location": {"width": 66, "top": 1438, "height": 24, "left": 277}, "words": "乳腺"}, {"probability": {"variance": 0.005432, "average": 0.971596, "min": 0.613483}, "location": {"width": 687, "top": 1440, "height": 58, "left": 260}, "words": "些研究中报道,绝经后妇女使用雌激素和孕激素与乳腺风险培加有关"}], "language": 3}